143536-52-1

Basic information

• Product Name: ethyl 5-(3-hydroxyphenyl)pentanoate
• Synonyms: ethyl 5-(3-hydroxyphenyl)pentanoate;Benzenepentanoic acid, 3-hydroxy-, ethyl ester
• CAS NO: 143536-52-1
• Molecular Formula: C₁₃H₁₈O₃
• Molecular Weight: 222.282
• Mol File: 143536-52-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 346.4 °C at 760 mmHg
• Flash Point: 142.5 °C
• Appearance: /
• Density: 1.075
• Vapor Pressure: 2.89E-05mmHg at 25°C
• Refractive Index: 1.517
• CAS DataBase Reference: ethyl 5-(3-hydroxyphenyl)pentanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 5-(3-hydroxyphenyl)pentanoate(143536-52-1)
• EPA Substance Registry System: ethyl 5-(3-hydroxyphenyl)pentanoate(143536-52-1)

Safety Data

• Hazardous Substances Data: 143536-52-1(Hazardous Substances Data)

Usage

General Description

Ethyl 5-(3- hydroxyphenyl)pentanoate is a chemical compound with the molecular formula C13H18O3. It is also known as ethyl vanillin pentanoate and is derived from vanillin, which is a primary component of the vanilla bean. ethyl 5-(3-hydroxyphenyl)pentanoate is commonly used as a flavoring agent in food and beverages due to its sweet, creamy, and slightly spicy aroma. It is also used in the production of perfumes and cosmetics for its pleasant scent. Ethyl 5-(3- hydroxyphenyl)pentanoate is a versatile compound with various applications in the flavor and fragrance industry.

InChI:InChI=1/C13H18O3/c1-2-16-13(15)9-4-3-6-11-7-5-8-12(14)10-11/h5,7-8,10,14H,2-4,6,9H2,1H3

Upstream product

• 1400705-30-7 5-(3-hydroxy-phenyl)-4-pentenoic acid ethyl ester 
• 1968-40-7 ethyl 4-pentenoate 
• 626-02-8 3-Iodophenol 
• 100-83-4 meta-hydroxybenzaldehyde 
• 13709-05-2 3-methoxymethoxybenzaldehyde 
• 1314760-23-0 C₁₁H₁₄O₃ 
• 1314760-24-1 C₁₅H₂₀O₄ 
• 14755-02-3 3-hydroxycinnamic acid 
• 3943-96-2 3-(3-hydroxyphenyl)acrylic acid ethyl ester 
• 160721-22-2 ethyl (E)-5-<3-(benzyloxy)phenyl>-2-pentenoate 
• 96251-92-2 (E)-3-(3-hydroxyphenyl)acrylic acid ethyl ester 
• 75849-10-4 ethyl 3-<3-(benzyloxy)phenyl>propanoate 
• 34708-60-6 3-(3-hydroxy-phenyl)propionic acid ethyl ester 
• 14755-02-3 3-hydroxy-trans-cinnamic acid 

Downstream Products

• 1400706-24-2 C₁₆H₂₂O₂S 
• 1400706-25-3 C₁₄H₂₀N₂O 
• 1400705-51-2 2-[4-(3-allyloxy-phenyl)butyl]-4,6-dimethyl-pyrimidine-5-carboxylic acid methyl ester 
• 1400706-21-9 C₂₉H₄₀N₄O₆ 
• 1400706-22-0 C₂₉H₃₄N₄O₅S 
• 1400706-23-1 C₂₆H₃₀N₄O₅S 
• 1400703-82-3 (S)-2-({2-[4-(3-hydroxy-phenyl)butyl]-4,6-dimethyl-pyrimidine-5-carbonyl}amino)-3-[(thiophene-2-carbonyl)amino]propionic acid 

Relevant articles and documents

PYRIMIDINE AMIDE COMPOUNDS

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, asthma and COPD.

COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF

A compound having an ability to bind to an S1P receptor (particularly EDG-6, preferably EDG-1 and EDG-6), for example, the compound represented by formula (I) of the present invention, a salt thereof, a solvate thereof or a prodrug thereof is useful for prevention and/or treatment of rejection of transplantation, graft-versus-host disease, autoimmune disease, allergic disease and the like. wherein ring A is a cyclic group; ring B is a cyclic group which may have substituent(s); X is a spacer having 1 to 8 atoms in its main chain, etc.; Y is a spacer having 1 to 10 atoms in its main chain, etc.; n is 0 or 1, wherein when n is 0, m is 1 and R1 is a hydrogen atom or a substituent, and wherein when n is 1, m is 0 or an integer of 1 to 7 and R1 is a substituent, and wherein m is 2 or more, R1s are the same or different.

Tandem Reduction / Intramolecular Hydroxyalkylation of (3-Hydroxyphenyl)alkanoates: a New Regioselective Approach to 1,8-Dihydroxytetralins

4-(3-hydroxyphenyl)-butanoates 4, on treatment with DIBALH, followed by hydrolytic work-up, undergo a novel completely regioselective intramolecular hydroxyalkylation reaction to give 1,8-dihydroxytetralins.The yield of the reaction depends heavily on the structure of starting material, best results being achieved with 3,3-disubstituted butanoates.